Catheter Precision Inc.

(AMEX:VTAK) stock traded higher during Friday's session after the stock gained nearly 25% over the week.

The rally follows a series of company announcements that boosted investor sentiment.

Earlier this week, the stock jumped 17.39% after Catheter Precision announced a partnership with GSE Worldwide and secured new patents covering its heart failure and vascular closure technologies.

The company also said its regional air mobility subsidiary, Flyte, partnered with GSE Worldwide and PGA Tour professional Emiliano Grillo.